G. Hancock

发表

Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects

J. Martinez-Picado, E. Giannoulatou, B. Angus, 2017, Journal of the International AIDS Society.

Improved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection.

B. Angus, J. Mak, R. Smyth, 2013, Journal of immunological methods.

Identification of Effective Subdominant Anti-HIV-1 CD8+ T Cells Within Entire Post-infection and Post-vaccination Immune Responses

C. Brander, N. Frahm, A. McMichael, 2015, PLoS pathogens.

A multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteins

Joshua Blight, C. López-Camacho, L. Dorrell, 2019, Scientific Reports.

Comprehensive Cardiac Magnetic Resonance Imaging and Spectroscopy Reveal a High Burden of Myocardial Disease in HIV Patients

S. Piechnik, S. Neubauer, K. Clarke, 2013, Circulation.

HIV-1–Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema

S. Piechnik, S. Neubauer, K. Clarke, 2016, Circulation. Cardiovascular imaging.

Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors

B. Jakobsen, P. Molloy, L. Dorrell, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

MS‐Rescue: A Computational Pipeline to Increase the Quality and Yield of Immunopeptidomics Experiments

Morten Nielsen, Massimo Andreatta, Annalisa Nicastri, 2019, Proteomics.

Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infection.

A. McMichael, B. Angus, Hao Wu, 2012, The Journal of infectious diseases.

decline in HIV-1 infection

B. Angus, Hao Wu, T. Denny, 2012 .

Emergence of a distinct HIV‐specific IL‐10‐producing CD8+ T‐cell subset with immunomodulatory functions during chronic HIV‐1 infection

I. Williams, A. McMichael, P. Borrow, 2013, European journal of immunology.

Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects.

A. McMichael, T. Hanke, P. Hayes, 2010, Vaccine.

Therapeutic HPV vaccines.

L. Dorrell, G. Hancock, K. Hellner, 2017, Best practice & research. Clinical obstetrics & gynaecology.

Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer

Isaac B. Woodhouse, S. Salatino, R. Parker, 2023, iScience.

Synergistic effect of human immunodeficiency virus and the metabolic syndrome on arterial stiffness

K. Clarke, C. Holloway, O. Rider, 2012 .

HIV is an independent predictor of aortic stiffness

S. Neubauer, K. Clarke, C. Holloway, 2014, Journal of Cardiovascular Magnetic Resonance.

Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infection.

A. McMichael, B. Angus, Hao Wu, 2012, Journal of Infectious Diseases.

HIV-1–Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema

S. Piechnik, S. Neubauer, K. Clarke, 2016, Circulation. Cardiovascular imaging.

Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions

T. Hanke, J. Frater, L. Dorrell, 2023, Scientific reports.

Emergence of a distinct HIV‐specific IL‐10‐producing CD8+ T‐cell subset with immunomodulatory functions during chronic HIV‐1 infection

I. Williams, A. McMichael, P. Borrow, 2013, European journal of immunology.